Filing Details

Accession Number:
0001209191-22-057418
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-16 20:00:11
Reporting Period:
2022-11-14
Accepted Time:
2022-11-16 20:00:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1630627 Treace Medical Concepts Inc. TMCI Surgical & Medical Instruments & Apparatus (3841) 471052611
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856371 F. Sean Scanlan C/O Treace Medical Concepts, Inc.
100 Palmetto Park Place
Ponte Vedra FL 32081
Svp, Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-14 25,000 $0.10 34,975 No 4 M Direct
Common Stock Disposition 2022-11-14 25,000 $24.27 9,975 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-11-14 25,000 $0.10 25,000 $0.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
108,750 2018-12-15 2024-12-15 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. Includes 9,975 RSUs.
  3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from$23.8000 to $24.5500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of theSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within therange set forth in this footnote.